Pure Global
NCT06365697

Evaluation of the Ton-bridge Carotid Stent for Carotid Artery Stenosis

Efficacy and Safety of the Ton-bridge Carotid Stent for the Treatment of Carotid Artery Stenosis: a Prospective, Multicenter, Non-inferiority, Randomized Controlled Trial
Zhuhai Tonbridge Medical Tech. Co., Ltd.·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carotid Artery Stenosis
Drug/Device/Intervention
Ton-bridge carotid stent
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Location
Shenyang,Linyi,Qingdao,Qingdao,Jinan,Lishui,Beijing, China
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Oct 01, 2025
Enrollment
188 participants
Primary outcome

Incidence of non-MAE(major adverse events) within 30 days post-procedure

Summary

The purpose of this trial is to evaluate effectiveness and safety of the Ton-bridge carotid
 stent for the treatment of carotid artery stenosis.

ICD-10 classifications
Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06365697
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06365697 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhuhai Tonbridge Medical Tech. Co., Ltd. and is currently Not yet recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 188 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.